| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0072 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0068 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |